Cabergoline and impulse control disorders: Screening patients with pituitary adenomas in an endocrinology clinic

Key Points

• Impulse control disorders are prevalent in patients receiving cabergoline treatment for pituitary adenomas,
• 42% of patients screened exhibited impulsive behaviors during the assessment,
• Analysis of patients from an endocrinology clinic revealed important correlations with cabergoline use,
• Findings highlight the need for careful monitoring and screening for impulse control disorders in this population.